Skip to main content
Caplight Logo









Lilly Asia Ventures

Lilly Asia Ventures

Hong Konglavfund.com

Overview

Lilly Asia Ventures is a biomedical venture capital firm that invests in biopharmaceuticals, human therapeutics, medical devices, and diagnostics.

Year Founded

2008

Portfolio Companies

93

Investments

Lilly Asia Ventures investments
CompanyDateStageLead
United InnoMedSep 2026Series BCo-investor
NeuShen TherapeuticsSep 2026Series BCo-investor
Convergen Suzhou Pharmaceutical Co. Ltd.Aug 2026SeedCo-investor
Khartis TherapeuticsAug 2026Series BCo-investor
Jiajin Biopharmaceutical (Shanghai) Co., Ltd.Jun 2026Series B++Lead
View all investments

Sector & Stage Mix

Industry, funding stage, and valuation band breakdowns.

Premium
SeedSeries ASeries BGrowth

Unlock portfolio analytics

Sign up to view full sector, stage, and valuation breakdowns for this investor.

Investment Activity

Yearly cadence, pace, and funding raised over time.

Premium
2021
2022
2023
2024
2025
2026

Unlock portfolio analytics

Sign up to explore yearly investment trends and funding raised over time.

FAQ

Firmographic Details

HeadquartersHong Kong
Year Founded2008

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?